
The FDA’s new CBER Safety Council separates post-market biologics safety review from approvals, raising oversight for cell and gene therapy developers.
Click the title above to open the Pharmaceutical Technology January 2018 issue in an interactive PDF format.
almost 9 years ago
Pharma Equipment Gets Smartalmost 9 years ago
Selecting and Installing Peristaltic Pump Tubingalmost 9 years ago
Boosting Functionality of Container Closuresalmost 9 years ago
Pharma Braces Itself for Post-Brexit Regulatory Changesalmost 9 years ago
Tackling the Opioid Crisis with Abuse-Deterrent Formulationsalmost 9 years ago
Elucidating Parenteral Packaging Requirements for Future Drugsalmost 9 years ago
In-Line Force Analysis During Vial Fillingalmost 9 years ago
Glass or Plastic—A Question of Usealmost 9 years ago
Additional Size for Quaternary Diaphragm Pumpsalmost 9 years ago
Single-Use Filling Assemblies for Aseptic Fill/Finish Applications




